Looking for great stocks to be had at a bargain? Even though broader equities have performed well this year, there are companies, particularly in sectors that haven't kept up with the rest of the market, that look affordable at current levels. One such sector is healthcare.

Two leading medical stocks that appear reasonable at current levels are AbbVie ( ABBV 0.80% ) and Merck ( MRK +0.33% ) . The former has actually beaten the market in 2025, while the latter is in the red year to date. However, looking ahead to 2026, both drugmakers are attractive stocks to buy.

1. AbbVie

As the saying goes, what doesn't kill you makes you stronger. That may apply to AbbVie, which lost patent exclusivity for the best-selling medicine in the industry's history, immunology drug Humira, in

See Full Page